BOLD - Boundless Bio GAAP EPS of -$12.27 misses by $11.54 May, 13 2024 09:47 AM Audentes Therapeutics Inc. 2024-05-13 09:47:09 ET More on Boundless Bio, Inc. Boundless Bio Starts $100 Million U.S. IPO Plan Bayer-backed Boundless Bio sees stock fall 8% after $100M IPO Boundless Bio prices $100M IPO at $16 per share Historical earnings data for Boundless Bio, Inc. Financial information for Boundless Bio, Inc. For further details see: Boundless Bio GAAP EPS of -$12.27 misses by $11.54